ALEBUND-B(09637.HK) closed 44.47% lower, the Hang Seng Pharmaceuticals & Biotechnology Sector saw divergent trends

By the close of trading on Jul 2, 2026, ALEBUND-B(09637.HK) saw a loss of 44.47% in its share price, closing at HKD 25.5. During the session, it reached an intraday high of HKD 39.04 and touched an intraday low of HKD 22.72. The full-day turnover stood at HKD 229.64 million, with the latest market capitalization at HKD 5.79 billion.

On the sector front, the Hang Seng Pharmaceuticals & Biotechnology Sector, to which ALEBUND-B belongs, showed an overall divergence trend, with 107 stocks advancing and 46 stocks declining.Among the gainers, VISEN PHARMA-B closed higher by 25.13%, DUALITYBIO-B closed higher by 15.45%, HJ SCIENCE-B closed higher by 15.38%, JW THERAP-B closed higher by 12.5%, JIUYUAN GENE closed higher by 12.2%.Among the decliners, IMPACT THERAP-B closed lower by 45.4%, ALEBUND-B closed lower by 44.47%, JIANGXI BIO closed lower by 35.58%, LONGBIO-B closed lower by 29.82%, CANBRIDGE-B closed lower by 25.93%.

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.